Abstract
European children and paediatricians rely heavily on the fair, complete and timely publication of data obtained from paediatric randomised controlled trials (RCTs). Selective publication and reporting of paediatric RCTs is common practice. Industry-sponsored trials are more likely to remain unpublished, and take longer to get published compared with trials sponsored by others. However, also academic sponsors contribute to inefficiencies in publishing clinical data. Publication bias violates the ethical obligation that investigators have towards study participants, leads to considerable inefficiencies in research and a waste of financial and human resources, and has the potential to distort evidence for treatment approaches.
Conclusion: The European Academy of Paediatrics (EAP) therefore actively supports initiatives that increase the public dissemination of paediatric clinical trial data. The EAP will raise awareness about the guidelines for Good Publication Practice among European paediatricians and subspecialty societies.
Abbreviations
- BMJ:
-
British Medical Journal
- EAP:
-
European Academy of Paediatrics
- EMA:
-
European Medicines Agency
- GPP:
-
Good publication practice
- RCT:
-
Randomised controlled trial
- SSRI:
-
Selective serotonin reuptake inhibitor
References
Battisti WP, Wager E, Baltzer L et al (2015) Good publication practice for communicating company-sponsored medical research: GPP3. Ann Intern Med 163:461–464
Hamm MP, Hartling L, Milne A, Tjosvold L, Vandermeer B, Thomson D, Curtis S, Klassen TP (2010) A descriptive analysis of a representative sample of pediatric randomized controlled trials published in 2007. BMC Pediatr 10:96
Hartling L, Craig WR, Russell K, Stevens K, Klassen TP (2004) Factors influencing the publication of randomized controlled trials in child health research. Arch Pediatr Adolesc Med 158:983–987
Iacobucci G (2016) Nearly half of all trials run by major sponsors in past decade are unpublished. BMJ 355:i5955
Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpova I, Mahtani KR, Nunan D, Howik J, Heneghan CJ (2014) Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. Apr 10;(4):CD008965. https://doi.org/10.1002/14651858.CD008965.pub4
Kelly M, Rees T and Smith S (2013) Good Publication Practice: The awareness and views of healthcare professionals. Industry Report conducted by EPG Health Media and Parexel International. March 2013, pages 1-6
Klassen T, Wiebe N, Russell K, Stevens K, Hartling L, Craig WR, Moher D (2002) Abstracts of randomized controlled trials presented at the Society for Pediatric Research Meeting: an example of publication bias. Arch Pediatr Adolesc Med 156:474–479
Manzoli L, Flacoo ME, D’Addario M et al (2014) Non-publication and delayed publication of randomized trials on vaccines: survey. BMJ 348:g3058
McGauran N, Wieseler B, Kreis J, Schuler Y, Kolsch J, Kaiser T (2010) Reporting bias in medical research—a narrative review. Trials 11:37
Pica N and Bourgeois F (2016) Discontinuation and nonpublication of randomized clinical trials conducted in children. Pediatrics 138(3). https://doi.org/10.1542/peds.2016-0223
Rosati P, Porzsolt F, Ricciotti G et al (2016) Major discrepancies between what clinical trial registries record and paediatric randomised controlled trials publish. Trials 17:430
Saint-Raymond A, Pelle B, Zaccaria C, Sennwitz M, Branch S (2016) Usage of unpublished paediatric data. Arch Dis Child 101:81–84
Salami J, Alkayed K (2013) Publication bias in pediatric hematology and oncology: analysis of abstracts presented at the annual meeting of the American Society of Pediatric Hematology and Oncology. Pediatr Hematol Oncol 30:165–169
Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E (2004) Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363:1341–1345
Who’s not sharing their trial results? https://trialstracker.ebmdatalab.net
World Medical Association Declaration of Helsinki (2013) Ethical principles for medical research involving human subjects. Adopted by the 18th WMA general assembly, Helsinki, Finland, June 1964 and amended by the 64th WMA GA, Fortaleza, Brazil. JAMA 310(20):2191–94
Author information
Authors and Affiliations
Contributions
Tom Stiris initiated the EAP viewpoint, commented on the draft and agreed on its final wording. Lenneke Schrier wrote the draft, included revisions from co-authors and agreed on its final wording. Karoly Illy commented on the draft and agreed on its final wording. Arunas Valiulis commented on the draft and agreed on its final wording. Corinne Wyder commented on the draft and agreed on its final wording.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants performed by any of the authors. Therefore, obtaining informed consent was not applicable, nor are funded studies included.
Additional information
Communicated by Peter de Winter
Rights and permissions
About this article
Cite this article
Schrier, L., Illy, K., Valiulis, A. et al. EAP viewpoint on unpublished data from paediatric clinical trials. Eur J Pediatr 177, 275–277 (2018). https://doi.org/10.1007/s00431-017-3005-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-017-3005-x